| Issue Date | Title | Author(s) | Type | Мp-cat. |
|---|---|---|---|---|
| 2025 | Antimicrobial Prophylaxis in Elective Orthopaedic Surgical Procedures at the Tertiary Care Hospital: A Prospective Observational Study![]() | Kosić, Milica; Miljković, Branislava | Article | 21aM21a |
| 2025 | Uticaj anemije na koncentracije infliksimaba i ishode lečenja kod pacijenata sa inflamatornim bolestima creva![]() | Homšek, Ana | Conference Paper | Mp. category will be shown later |
| 2025 | Comparative in silico/in vitro analysis of pharmacokinetic profiles of BET inhibitors![]() | Koravovic, Mladen D | Article | 23M23 |
| 2025 | Bleeding risk and drug interactions in patients with atrial fibrillation taking oral anticoagulants![]() | Kovačević, Milena | Article | 51M51 |
| 2025 | A Clinical Perspective of Therapeutic Drug Monitoring of Cyclosporine in Pediatric Patients with Kidney Transplant![]() | Roganović, Maša | Article | 51M51 |
| 2025 | Real-World Safety of Vedolizumab in Inflammatory Bowel Disease: A Retrospective Cohort Study Supported by FAERS Signal Analysis![]() | Milašinović, Bojana | Article | 21aM21a |
| 2025 | Potential QT-prolonging drug-drug interactions in cardiovascular disease patients![]() | Kovačević, Milena | Article | 23M23 |
| 2024 | Role of Pharmacists in the Management of Patients with Obesity | Jovanović, Marija | Article | 51M51 |
| 2024 | Potentially inappropriate prescribing in elderly patients across healthcare settings: application of STOPP/START version 2 criteria![]() | Kovačević, Milena | Article | 22M22 |
| 2024 | Understanding hemoglobin contribution to high-dose methotrexate disposition—population pharmacokinetics in pediatric patients with hematological malignancies![]() | Škorić, Biljana; Jovanović, Marija | Article | 22M22 |
| 2024 | Review and External Evaluation of Population Pharmacokinetic Models for Vedolizumab in Patients with Inflammatory Bowel Disease: Assessing Predictive Performance and Clinical Applicability![]() | Jovanović, Marija | Article | 21M21 |
| 2024 | Vedolizumab Clearance as a Surrogate Marker for Remission in Inflammatory Bowel Disease Patients: Insights from Real-World Pharmacokinetics![]() | Marković, Srđan | Article | 21aM21a |
| 2023 | Pharmacokinetic characterization, benefits and barriers of subcutaneous administration of monoclonal antibodies in oncology![]() | Homšek, Ana | Article | 23M23 |
| 2023 | Lidocaine Clearance as Pharmacokinetic Parameter of Metabolic Hepatic Activity in Patients with Impaired Liver | Jovanović, Marija | Article | 23M23 |
| 2023 | Modelling fatigue events in prostate cancer patients on radiotherapy![]() | Roganović, Maša | Conference Paper | Mp. category will be shown later |
| 2023 | Association of clozapine and norclozapine levels with patient and therapy characteristics—focus on interaction with valproic acid![]() | Panić, Bojana; Jovanović, Marija | Article | 22M22 |
| 2023 | Potentially inappropriate prescribing among older patients and associated factors: comparison of two versions of STOPP/START criteria![]() | Jovanović, Marija | Article | 23M23 |
| 2023 | Population pharmacokinetic model of infliximab in patients with fistulising Crohn’s disease![]() | Homšek, Ana | Conference Paper | Mp. category will be shown later |
| 2023 | COVID-19 and Behavioral Factors of e-Payment Use: Evidence from Serbia![]() | Milosavljević, Miloš | Article | 21M21 |
| 2023 | Review of the Clinical Pharmacokinetics, Efficacy and Safety of Pembrolizumab![]() | Homšek Ana | Article | 22M22 |